Christophe Bardin

Université Paris Cité — France

Medicine · Health Sciences

20h-index2.7kcitations109works1.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Pharmaceutical Practices and Patient Outcomes(13), French Urban and Social Studies(9), Pharmaceutical studies and practices(9), Safe Handling of Antineoplastic Drugs(8), Cultural Insights and Digital Impacts(8)

Publications107 total

The evolving role of Hospital Oncology Pharmacists (HOPs) in assessing therapeutic innovations and managing toxicities in cancer care
Annales Pharmaceutiques Françaises·2025
Oncology pharmacy practice: Key insights, challenges, and perspectives – A position paper from the French Society for Oncology Pharmacy (SFPO)
Annales Pharmaceutiques Françaises·2025· 1 cited
Randomised controlled trial to assess the impact of hospital–community pharmaceutical care on drug-related problems in oncology practice for at-risk outpatients treated with oral anticancer drugs—a French Society for Oncology Pharmacy (SFPO) study: DROP-SFPO study protocol
BMJ Open·2025Open Access
European Cancer Organisation Essential Requirements for Quality Cancer Care: Hematological malignancies
HemaSphere·2025· 1 citedOpen Access
SFPO and ESOP recommendations for the practical stability of anticancer drugs: second update
European Journal of Oncology Pharmacy·2024· 1 citedOpen Access
Clinical oncology pharmacy has become a reality: results of a member survey of the European Society of Oncology Pharmacy Global
European Journal of Oncology Pharmacy·2024· 4 citedOpen Access
Garantir l’accès et la sécurité d’utilisation de la dexaméthasone pour les patients atteints de myélome multiple
Bulletin du Cancer·2023· 1 cited
Ovarian cancer in the older patient: where are we now? What to do next?
Therapeutic Advances in Medical Oncology·2023· 13 citedOpen Access
Les analogues de l’insuline utilisés en thérapeutique sont-ils reconnus par les dosages d’insuline actuels ?
Annales d Endocrinologie·2021
Pilot study of a European oncology regimen reference library and matching algorithm
European Journal of Hospital Pharmacy·2021Open Access
Drug-Drug Interaction between Metformin and Sorafenib Alters Antitumor Effect in Hepatocellular Carcinoma Cells
Molecular Pharmacology·2021· 15 citedOpen Access
Identifying options for oncology therapy regimen codification to improve standardization—combined results of an expert panel and a review
Journal of Clinical Pharmacy and Therapeutics·2021· 3 citedOpen Access
Cancer, immune suppression and Coronavirus Disease-19 (COVID-19): Need to manage drug safety (French Society for Oncology Pharmacy [SFPO] guidelines)
Cancer Treatment Reviews·2020· 54 citedOpen Access
Providing Oncology Pharmacy Services During the Coronavirus Pandemic: French Society for Oncology Pharmacy (Société Francaise de Pharmacie Oncologique [SFPO]) Guidelines
JCO Oncology Practice·2020· 10 cited
Les auteurs
Elsevier eBooks·2020
Art Glasses
Springer handbooks·2019
PS-069 Simulation training: an innovative and efficient tool to teach medication reconciliation to pharmacy students
2017
CP-240 The clinical pharmacist resolves medication relative problems in oncologic patients. is it true?
2017
La simulation : un outil innovant et efficace de formation des étudiants en pharmacie à la conciliation médicamenteuse
Le Pharmacien Hospitalier et Clinicien·2016
Connaissances des patients hospitalisés concernant leurs traitements chroniques : évaluer pour mieux informer
Le Pharmacien Hospitalier et Clinicien·2016
page 1 of 6Next →

Frequent Co-authors

F. Chast(10), François Chast(8), Jean‐Marc Tréluyer(6), A. Astier(6), Isabelle Madelaine(6), Xavier Declèves(4), Saı̈k Urien(4), Florian Slimano(4), Jean‐François Tournamille(4), Catherine Rioufol(4), Pierre Quartier(3), Nicolas Widmer(3), Étienne Chatelut(3), Angélo Paci(3), Jos H. Beijnen(3), Dominique Levêque(3), Gareth J. Veal(3), Jean Vigneron(3), Mikaël Daouphars(3), Déborah Hirt(3)